A bill to extend the patent term of certain products.

openUnited States· United States Congress· EN

Introduced

23 May 1991

Last action

22 September 1992 · Reported

Status

Placed on Senate Legislative Calendar under General Orders. Calendar No. 695.

Summary

Amends Federal patent law to extend the patent term for certain drugs composed of non-steroidal anti-inflammatory agents if during the regulatory review process: (1) the patentee filed a new drug application in 1982; (2) the patentee awaited approval by the Food and Drug Administration for at least 78 months; and (3) such new drug application was approved in 1988. Prescribes a formula for patent term extension, and sets forth administrative notification procedures.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

23 May 1991
Introduced
Read twice and referred to the Committee on Judiciary.
Source: IntroReferral
23 May 1991
Introduced
Introduced in Senate
Source: IntroReferral
7 June 1991
Referred
Referred to Subcommittee on Patents, Copyrights and Trademarks.
Source: Committee
1 August 1991
Committee
Subcommittee on Patents, Copyrights and Trademarks. Hearings held. Hearings printed: S.Hrg. 102-824.
Source: Committee
21 May 1992
Committee
Subcommittee on Patents, Copyrights and Trademarks. Approved for full committee consideration with an amendment in the nature of a substitute favorably.
Source: Committee
12 August 1992
Reported
Committee on Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Source: Committee
22 September 1992
Calendars
Placed on Senate Legislative Calendar under General Orders. Calendar No. 695.
Source: Calendars
22 September 1992
Reported
Committee on Judiciary. Reported to Senate by Senator Biden with an amendment in the nature of a substitute and an amendment to the title. With written report No. 102-414.
Source: Committee
22 September 1992
Reported
Committee on Judiciary. Reported to Senate by Senator Biden with an amendment in the nature of a substitute and an amendment to the title. With written report No. 102-414.
Source: Committee

Votes

No vote records are attached yet.

Versions

Introduced in Senate · — · Download file
Reported to Senate · — · Download file

Documents

4 official files

Reported to Senate (text)

View file Download file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Reported to Senate (text)
Reported to Senate · EN
View Download Open at official source
Introduced in Senate (text)
Introduced in Senate · EN
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Reported to Senate with amendment(s)
summary · EN · 22 September 1992
Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in Senate
summary · EN · 23 May 1991
Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

related to → To extend the patent term of certain products.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/102nd-congress/senate-bill/1165
Open data entity: https://api.congress.gov/v3/bill/102/s/1165
us · 102-s-1165 · source updated 10 August 2026